Gian Life Care Board of Directors
Get the latest insights into the leadership at Gian Life Care. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Arun Kumar Gupta | Managing Director |
| Mrs. Rashika Agarwal | Non Executive Woman Director |
| Mr. Abhiram Saran Agarwal | Ind. Non-Executive Director |
| Mr. Umang Gupta | Ind. Non-Executive Director |
| Mr. Ramesh Yadav | Ind. Non-Executive Director |
| Mr. Shivam Mamgain | Non Executive Director |
Gian Life Care Share price
GIANLIFE
15.98
0.07 (0.44%)Last updated on 24 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
16.17
Today's Low
15.60
52 Week Low
12.06
52 Week High
23.39
The current prices are delayed, login to your account for live prices
LoginGian Life Care FAQs
The board at Gian Life Care consists of experienced professionals, including Mr. Arun Kumar Gupta , Mrs. Rashika Agarwal , and others, overseeing the company’s strategic and corporate governance.
Directors at Gian Life Care are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Arun Kumar Gupta is the current chairman at Gian Life Care.
Executive directors at Gian Life Care are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Gian Life Care adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Gian Life Care, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.